Fidelity Investments’s Terns Pharmaceuticals TERN Stock Holding History

Fidelity Investments’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80,000	Closed	-$4.22M	–	5715
2026 Q1	$4.22M	Buy	+80,000	New	+$3.29M	﹤0.01%	2359

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fidelity Investments's TERN Position: Q2 2026 in Review

Fidelity Investments sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 295,622 shares — an estimated $15.6M sold.

Fidelity Investments first reported a position in TERN in Q1 2021 and held it in 21 quarters. The position peaked at $90.5M in Q1 2023. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Fidelity Investments reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fidelity Investments sold 295,622 Terns Pharmaceuticals shares in Q2 2026, an estimated $15.6M.
Fidelity Investments first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 21 quarters.
Fidelity Investments's Terns Pharmaceuticals position peaked at $90.5M in Q1 2023.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.